The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 25, 2021
Filed:
Mar. 13, 2017
Applicant:
Oryzon Genomics S.a., Madrid, ES;
Inventors:
Filippo Ciceri, Barcelona, ES;
Serena Lunardi, Boston, MA (US);
Tamara Maes, Castelldefels, ES;
Cristina Mascaro Crusat, Barcelona, ES;
Inigo Tirapu Fernandez De La Cuesta, Vienna, AT;
Assignee:
Oryzon Genomics S.A., Madrid, ES;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61P 35/02 (2006.01); A61K 31/135 (2006.01); A61K 31/17 (2006.01); A61K 31/203 (2006.01); A61K 31/282 (2006.01); A61K 31/015 (2006.01); A61K 31/337 (2006.01); A61K 31/4045 (2006.01); A61K 31/4745 (2006.01); A61K 31/475 (2006.01); A61K 31/519 (2006.01); A61K 31/555 (2006.01); A61K 31/704 (2006.01); A61K 31/7068 (2006.01); A61K 31/19 (2006.01); A61P 35/00 (2006.01); A61K 31/496 (2006.01); A61K 33/36 (2006.01); A61K 31/64 (2006.01);
U.S. Cl.
CPC ...
A61K 31/015 (2013.01); A61K 31/12 (2013.01); A61K 31/135 (2013.01); A61K 31/17 (2013.01); A61K 31/19 (2013.01); A61K 31/203 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/4045 (2013.01); A61K 31/475 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/555 (2013.01); A61K 31/64 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01); A61K 33/36 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01);
Abstract
The instant invention relates to combinations of the compound of formula (I) or pharmaceutically acceptable salts thereof with other active pharmaceutical ingredients pharmaceutical compositions comprising them, and their use as medicaments, particularly for the treatment of hematological malignancies.